The theme for this year’s CLINAM meeting is Targeted Delivery and Precision Medicine ‐ The Building Blocks to Personalized Medicine. This year, Scott McNeil, NCL’s Director, and Jeff Clogston, NCL’s lead for nanomaterial physicochemical characterization, have both been invited to speak at the conference. Scott will be speaking in the session “Global Clinical Experience with Non‐Biological Complex Drugs (NBCDs) and their Follow‐on Versions: Are we Closer to Regulatory Alignment?” Jeff will be speaking in the session on “Sizing of Nanoparticles: From Regulatory and Metrology Aspects to Application and Analysis.” Please feel free to reach out to Scott or Jeff to learn more about the NCL or to discuss applying to our program.
For more information on the meeting, please visit https://www.clinam.org/. The call for oral and poster presentations is now open. The call for oral presentations closes May 31, 2018, and the call for poster presentations closes July 1, 2018.